查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040409

神經血管微導管市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測（2026-2033 年）

Neurovascular Microcatheter Market Size, Share, & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

神經血管微導管市場概述

2025 年全球神經血管微導管市場價值為 7.0398 億美元，預計到 2033 年將達到 12.2473 億美元，2026 年至 2033 年的複合年成長率為 7.07%。

神經血管動脈瘤的日益普遍推動了這個市場的發展，進而增加了對微創治療（如彈簧圈栓塞和血流導向）的需求，而精確的導管操作在這些治療中至關重要。

此外，缺血性中風發生率的上升是主要推動因素，因為這些裝置廣泛應用於機械取栓術，以快速有效地恢復血流。全球卒中負擔日益加重，尤其是在高齡化社會中，也進一步促進了市場成長。此外，高血壓病例的增加（高血壓是動脈瘤和中風的主要危險因子）導致需要神經血管介入治療的患者群體擴大，增加了對先進微導管技術的需求，並支持了全球市場的整體擴張。

神經血管動脈瘤發生率的上升顯著增加了對微創治療的需求，從而推動了神經血管微導管市場的擴張。早期診斷和及時干預至關重要，因為未經治療的腦動脈瘤可能會破裂，導致出血性中風等嚴重併發症。這促使血管內手術（包括彈簧圈栓塞術和血流導引術）的數量增加，而微導管對於精準地在複雜的腦血管中穿行至關重要。根據《2025年遺傳性腦動脈瘤支持計畫》，未破裂的腦動脈瘤（即腦血管中的局部凸起或腫脹）相對常見，影響英國約3%的人口，約200萬人。雖然大多數動脈瘤無症狀且不會引起任何問題，但每年仍有少量（3000至5000例）動脈瘤破裂，其中約一半會導致死亡。此外，影像技術的進步以及病患和醫護人員意識提升正在提升早期檢出率。由於恢復期更短、手術風險更低，微創技術的應用正在加速普及。

「腦動脈瘤通常不會引起症狀，但它們可能在毫無預兆的情況下破裂，導致災難性後果。事實上，大多數腦動脈瘤都不會破裂，但目前尚無方法識別出少數會破裂的動脈瘤。儘管在闡明臨床危險因素方面已取得顯著進展，但我們對腦動脈瘤發展背後的遺傳因素以及破裂原因的了解仍然非常有限，儘管這種疾病可能影響英國3%的人口。

由於中風發病率不斷上升，神經血管微導管市場正在擴張。這是因為及時有效的治療性介入需求顯著增加。在佔大多數的缺血性中風病例中，需要進行機械取栓等手術來快速恢復腦部血流。神經血管微導管在這些手術中發揮著至關重要的作用，它們能夠精準地引導複雜的腦動脈，並實現器械的精確輸送。由於人口老化以及高血壓、糖尿病和肥胖等文明病相關的危險因素，中風的發生率不斷上升，因此，介入治療的數量也在增加。此外，人們對早期中風管理的認知不斷提高，以及醫療基礎設施的改善，進一步促進了神經血管微導管的應用，從而推動了市場成長。

技術進步顯著提升了血管內治療的性能、安全性和精準度，推動了神經血管微導管市場的成長。諸如更高的柔軟性、更小的內徑、更佳的貼合性和親水性塗層等創新技術，使得微導管能夠更輕鬆、更精準地穿行於複雜蜿蜒的腦血管中。 2025年，瑞士洛桑聯邦理工學院（EPFL）的研究人員開發出一種極為微小且高度柔軟性的神經血管微導管，能夠輕鬆穿行於複雜分支血管中。該裝置的關鍵特性在於其由自然血流驅動，從而能夠快速、安全地通過複雜的動脈通路，改善神經血管手術的導航性能並降低手術風險。

「導管消除了使用後取出裝置的擔憂，並且沒有負載容量的限制。但另一方面，許多血管位於傳統導管無法到達的位置，」Sakar解釋道。 「這就是我們開發和測試『MagFlow』的原因。它是一種超小型磁性微導管，尺寸僅為行業標準微導管的一半，它利用血流自身的動能來移動，從而最大限度地減少與血管壁的接觸。」——瑞士洛桑聯邦理工學院（EPFL）工程學院微生物機器人系統實驗室主任

雙腔可操作微導管的研發進一步提升了治療器械的可控性，並提高了栓塞術和血栓切除術等手術中靶向輸送的精確度。此外，與先進影像系統和即時導航技術的整合，改善了手術效果並降低了風險。這種持續的改善增強了醫生的信心，擴大了微創治療的範圍，並加速了神經血管微導管在整個醫療領域的應用。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：神經血管微導管市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 神經血管微導管市場分析工具

第4章：神經血管微導管市場：按類型（容量/型號）分類的估算和趨勢分析

  • 神經血管微導管市場：基於類型的波動分析
  • 神經血管微導管市場：按類型分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 單腔微導管
  • 雙腔球囊微導管

第5章：神經血管微導管市場：按應用分類的估算與趨勢分析

  • 神經血管微導管市場：基於應用的波動分析
  • 神經血管微導管市場：按應用領域分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 診斷服務
  • 治療性栓塞輸送
  • 暫時性阻塞/血流控制
  • 血管通路和導航
  • 其他

第6章：神經血管微導管市場：依最終用途分類的估算與趨勢分析

  • 神經血管微導管市場：依最終用途分類的波動分析
  • 神經血管微導管市場：依最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 醫院
  • 診所
  • 門診手術中心
  • 診斷中心

第7章：神經血管微導管市場：區域估算和趨勢分析（按類型、應用和最終用途分類）

  • 區域儀錶板
  • 神經血管微導管市場：區域波動分析、市場佔有率、2025 年和 2033 年預測
  • 神經血管微導管市場：區域預測與趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 參與企業的分類
  • Company Share Analysis, 2025
  • 主要公司簡介
    • Stryker
    • Medtronic
    • MicroVention（Terumo）
    • Balt
    • Johnson & Johnson（Cerenovus）
    • Penumbra（Boston Scientific Corporation）
    • Cook Medical
    • Merit Medical
    • Asahi Intecc
    • Integer Holdings
    • Acandis GmbH（Lauxera Capital Partners）
    • phenox GmbH（Wallaby Medical）
Product Code: GVR-4-68040-888-1

Neurovascular Microcatheter Market Summary

The global neurovascular microcatheter market size was valued at USD 703.98 million in 2025 and is projected to reach USD 1,224.73 million by 2033, growing at a CAGR of 7.07% from 2026 to 2033. The industry is driven by the rising prevalence of neurovascular aneurysms, which is increasing demand for minimally invasive procedures such as coiling and flow diversion, where precise catheter navigation is essential.

In addition, the growing incidence of ischemic stroke is a major factor, as these devices are widely used in mechanical thrombectomy procedures to restore blood flow quickly and effectively. The expanding global burden of stroke, particularly among aging populations, further supports market growth. Moreover, the rising cases of hypertension, a key risk factor for both aneurysms and strokes, are contributing to a larger patient pool requiring neurovascular interventions, thereby boosting the demand for advanced microcatheter technologies and supporting overall market expansion globally.

The rising prevalence of neurovascular aneurysms is growing the market for neurovascular microcatheters, as it significantly increases the demand for minimally invasive treatment procedures. Cerebral aneurysms, if left untreated, can rupture and lead to severe complications such as hemorrhagic stroke, prompting early diagnosis and timely intervention. This has led to an increasing number of endovascular procedures, including coil embolization and flow diversion, where microcatheters are essential for precise navigation through complex cerebral vessels. According to the Hereditary Brain Aneurysm Support 2025, unruptured brain aneurysms, localized bulges or swellings in the brain's blood vessels, are relatively common, affecting about 3% of the UK population, or roughly 2 million people. While most aneurysms remain asymptomatic and do not cause problems, a small number, between 3,000 and 5,000 cases each year, rupture, with approximately half of these resulting in fatal outcomes. In addition, advancements in imaging technologies and increasing awareness among patients and healthcare providers have improved early detection rates. The shift toward minimally invasive techniques, due to reduced recovery time and lower procedural risks, is further accelerating adoption.

"Brain aneurysms typically produce no symptoms but can burst without warning with catastrophic consequences. The reality is that most brain aneurysms will never rupture, but we currently have no way of identifying the minority that will. We are making great strides in understanding clinical risk factors but our ability to understand the genetics behind their development and understand why they rupture remains surprisingly limited for a condition that potentially impacts 3% of the UK population."- Professor Diederik Bulters, Consultant Neurosurgeon at UHS, Honorary Professor of Neurovascular Surgery at the University of Southampton, and Chief Investigator of the ROAR Study.

The rising prevalence of stroke is growing the market for neurovascular microcatheters, as it significantly increases the need for timely and effective treatment interventions. Ischemic strokes, which account for the majority of cases, require procedures such as mechanical thrombectomy to restore blood flow to the brain quickly. Neurovascular microcatheters play a vital role in these procedures by enabling precise navigation through complex cerebral arteries and supporting accurate device delivery. The increasing incidence of stroke, driven by aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity, is leading to a higher number of interventional procedures. In addition, growing awareness about early stroke management and improved healthcare infrastructure are further boosting the adoption of neurovascular microcatheters, thereby driving market growth.

Technological advancements are driving the neurovascular microcatheter market by significantly improving the performance, safety, and precision of endovascular procedures. Innovations such as enhanced flexibility, smaller diameters, improved trackability, and hydrophilic coatings enable microcatheters to navigate complex, tortuous cerebral vessels with greater ease and accuracy. In 2025, Researchers at EPFL developed an extremely small, highly flexible neurovascular microcatheter that can navigate complex, branching blood vessels with ease. Uniquely, the device is driven by natural blood flow, allowing it to travel quickly and safely through intricate arterial pathways, improving navigation and reducing the risk during neurovascular procedures.

"Catheters eliminate concerns about device removal after use, and don't have limited payloads. At the same time, many blood vessels lie beyond a traditional catheter's reach," Sakar explains. "That's why we have developed and tested MagFlow: an ultraminiaturized magnetic microcatheter - twice as small as benchmark microcatheters - that minimizes contact with vessel walls by hitching a ride on the blood stream's own kinetic energy." - head of the MicroBioRobotic Systems Laboratory in EPFL's School of Engineering

The development of dual-lumen, steerable microcatheters further enables better control and targeted delivery of therapeutic devices during procedures such as coil embolization and thrombectomy. In addition, integration with advanced imaging systems and real-time navigation technologies enhances procedural outcomes and reduces risks. These continuous improvements are increasing physician confidence, expanding the scope of minimally invasive treatments, and driving the adoption of neurovascular microcatheters across healthcare settings.

Global Neurovascular Microcatheter Market Report Segmentation

This report forecasts global, regional, and country-level revenue growth and analyzes the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurovascular microcatheter market report on the basis of type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Single-Lumen Microcatheters
  • Dual-Lumen Balloon Microcatheters
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic Delivery
  • Therapeutic Embolization Delivery
  • Temporary Occlusion / Flow Control
  • Vascular Access & Navigation
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neurovascular Microcatheter Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of neurovascular diseases
      • 3.2.1.2. Increasing adoption of minimally invasive neurovascular procedures
      • 3.2.1.3. Technological advancements in microcatheters
      • 3.2.1.4. Expansion of neurointerventional infrastructure and catheterization laboratories
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of neurovascular procedures and devices
      • 3.2.2.2. Stringent regulatory approval processes for neurovascular devices
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Increasing adoption of outpatient and ambulatory surgical centers
      • 3.2.3.2. Growing demand in emerging markets s
      • 3.2.3.3. Rising research and development investments in neurovascular devices
      • 3.2.3.4. Increasing awareness and early diagnosis of neurological disorders
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Complexity of neurovascular procedures
      • 3.2.4.2. High training requirements for physicians
  • 3.3. Neurovascular Microcatheter Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Microcatheter Market: Type (Capacity / Model-Based) Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurovascular Microcatheter Market: Type Movement Analysis
  • 4.3. Neurovascular Microcatheter Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Single-Lumen Microcatheters
    • 4.5.1. Single-Lumen Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Dual-Lumen Balloon Microcatheters
    • 4.6.1. Dual-Lumen Balloon Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurovascular Microcatheter Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurovascular Microcatheter Market: Application Movement Analysis
  • 5.3. Neurovascular Microcatheter Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Diagnostic Delivery
    • 5.5.1. Diagnostic Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Therapeutic Embolization Delivery
    • 5.6.1. Therapeutic Embolization Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Temporary Occlusion / Flow Control
    • 5.7.1. Temporary Occlusion / Flow Control Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Vascular Access & Navigation
    • 5.8.1. Vascular Access & Navigation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurovascular Microcatheter Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Neurovascular Microcatheter Market: End Use Movement Analysis
  • 6.3. Neurovascular Microcatheter Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Clinics
    • 6.6.1. Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ambulatory Surgical Centers
    • 6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Diagnostic Centers
    • 6.8.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurovascular Microcatheter Market: Regional Estimates & Trend Analysis, by Type, by Application, and by End Use

  • 7.1. Regional Dashboard
  • 7.2. Regional Neurovascular Microcatheter Market Movement Analysis & Market Share, 2025 & 2033
  • 7.3. Neurovascular Microcatheter Market: Regional Estimates & Trend Analysis
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Share Analysis, 2025
  • 8.3. Key Company Profiles
    • 8.3.1. Stryker
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Medtronic
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. MicroVention (Terumo)
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Balt
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Johnson & Johnson (Cerenovus)
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Penumbra (Boston Scientific Corporation)
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Cook Medical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Merit Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Asahi Intecc
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Integer Holdings
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Acandis GmbH (Lauxera Capital Partners)
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. phenox GmbH (Wallaby Medical)
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 4. North America Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 5. North America Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 6. North America Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 7. U.S. Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 8. U.S. Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 9. U.S. Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 10. Canada Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 11. Canada Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 12. Canada Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 13. Mexico Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 14. Mexico Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 15. Mexico Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 16. Europe Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 17. Europe Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 18. Europe Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 19. Europe Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 20. Europe Neurovascular microcatheter, by clinical indication, 2021 - 2033 (USD Million)
  • Table 21. UK Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 22. UK Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 23. UK Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 24. Germany Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 25. Germany Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 26. Germany Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 27. France Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 28. France Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 29. France Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 30. Italy Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 31. Italy Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 32. Italy Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 33. Spain Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 34. Spain Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 35. Spain Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 36. Denmark Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 37. Denmark Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 38. Denmark Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 39. Sweden Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 40. Sweden Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 41. Sweden Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 42. Norway Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 43. Norway Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 44. Norway Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 45. Asia Pacific Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 46. Asia Pacific Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 49. China Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 50. China Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 51. China Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 52. Japan Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 53. Japan Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 54. Japan Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 55. India Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 56. India Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 57. India Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 58. South Korea Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 59. South Korea Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 60. South Korea Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 61. Australia Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 62. Australia Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 63. Australia Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 64. Thailand Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 65. Thailand Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 66. Thailand Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 67. Latin America Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 68. Latin America Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 69. Latin America Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 70. Latin America Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 71. Brazil Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 72. Brazil Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 73. Brazil Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 74. Argentina Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 75. Argentina Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 76. Argentina Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 77. Middle East & Africa Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 78. Middle East & Africa Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 81. South Africa Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 82. South Africa Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 83. South Africa Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 84. Saudi Arabia Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 85. Saudi Arabia Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 86. Saudi Arabia Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 87. UAE Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 88. UAE Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 89. UAE Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 90. Kuwait Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 91. Kuwait Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 92. Kuwait Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Neurovascular Microcatheter Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Swot Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Neurovascular Microcatheter Market, Type Outlook Key Takeaways (USD Million)
  • Fig. 12 Neurovascular Microcatheter Market, Type Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 13 Single-Lumen Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Dual-Lumen Balloon Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Neurovascular Microcatheter Market, Application Outlook Key Takeaways (USD Million)
  • Fig. 16 Neurovascular Microcatheter Market, Application Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 17 Diagnostic Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Therapeutic Embolization Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Temporary Occlusion / Flow Control Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Vascular Access & Navigation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Neurovascular Microcatheter Market, End Use Outlook Key Takeaways (USD Million)
  • Fig. 23 Neurovascular Microcatheter Market, End Use Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 24 Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Neurovascular Microcatheter Market Regional Outlook, 2025 & 2033 (USD Million)
  • Fig. 29 North America Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 US Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Canada Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Europe Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 UK Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Germany Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 France Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Spain Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Italy Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Sweden Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Norway Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Denmark Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Asia Pacific Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 China Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Japan Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 India Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 South Korea Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Australia Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Thailand Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Argentina Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Middle East And Africa Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 South Africa Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Saudi Arabia Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 UAE Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 List Of Key Emerging Company's/Product Type Disruptors/Innovators